Healthcare • Biotechnology
EODHD (TTM) · as of Oct 13, 2026
End-of-day close from stored market data, not a live quote.
Sign in to see your position size
We’ll show you if CGON is in your portfolio and how much it contributes.
Sign inLoading market dates
No upcoming ex-dividend date announced
No 8-K filings in the last 30 days.
44 top institutions tracked
Last 13F trend: unchanged (light)
Unlock crowding heatmapUnlock filer discoverySentiment: bearish
Last trade: sell 28 days ago
Red flags: 0
228 filers reported a long position in CGON for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
| Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|
| RTW INVESTMENTS, LP | $605M | 8.5M | +21.9% |
| T. Rowe Price Investment Management, Inc. | $470.1M | 6.6M | -1.5% |
| Decheng Capital LLC | $452.7M | 6.4M | Unchanged |
| BlackRock, Inc. | $444.5M | 6.3M | +23.5% |
| WELLINGTON MANAGEMENT GROUP LLP | $378.3M | 5.3M | -0.9% |
| FMR LLC | $295.7M | 4.2M | +10.5% |
| PRICE T ROWE ASSOCIATES INC /MD/ | $270.3M | 3.8M | +4.2% |
| TCG Crossover Management, LLC | $260.8M | 3.7M | Unchanged |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $246.2M | 3.5M | +12% |
| STATE STREET CORP | $244.2M | 3.4M | +29.9% |
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.